Ribomic: Presentation materials at the International Skeletal Dysplasia Society international conference
Ribomic: Notice of NEDO's “Cyber-Physical Development Project for Quantum-Classical Hybrid Technology” Stage Gate Examination Passed
Ribomic: Presentation materials at The Retina Society international conference
Ribomic: Notice of European Patent Registration for Formulation Patents Related to umedaptanib pegol (anti-FGF2 aptamer)
Ribomic: Notice regarding the monthly exercise status of the 17th Stock Acquisition Rights (with exercise price amendment clause)
Ribomic: Change Report
Ribomic: Change Report
Ribomic: Announcement of individual stocks: Notification of presentation at the International Skeletal Dysplasia Society conference
Ribomic: Announcements of individual stocks regarding the recognition of non-operating income (foreign exchange gains)
Ribomic: Overview of non-consolidated financial statements for the three-month period ending on June 30, 2024 (based on Japanese accounting standards).
Ribomic: March 2025 1st quarter financial results text message [Japanese standard] (non-consolidated)
Ribomic: Announcement of revised financial estimates.
Ribomic: Announcements of subscription rights for the 17th time based on the facility contract (with exercise price adjustment clause) regarding the request for suspension of exercise.
Ribomic: [Delayed] RIBOMIC has announced the completion of patient registration for the initial Phase II trial of Umedaptanib Pegol for achondroplasia.
Ribomic: Announcements of individual stocks regarding the monthly exercise status of the 17th subscription rights (with exercise price adjustment clause).
Ribomic: Shareholder communications "RIBOMICation vol.10"
Ribomic: Change report.
Ribomic: Announcements of the exercise of a large number of Subscription Rights (with Exercise Price Adjustment Clause) in the 17th New Share Subscription Rights.
Ribomic: Change Report
Ribomic: Announcements of individual stocks: Signing of a joint research agreement on ophthalmology diseases with the University of Tokyo.
No Data
No Data